skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Methods of use of cellulose binding domain proteins

Abstract

A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques. 16 figs.

Inventors:
; ; ;
Issue Date:
Research Org.:
University of California
Sponsoring Org.:
USDOE, Washington, DC (United States)
OSTI Identifier:
541745
Patent Number(s):
5,670,623
Application Number:
PAN: 8-460,462
Assignee:
Yissum Research Development Co., Jerusalem (Israel);Univ. of California, Oakland, CA (United States) PTO; SCA: 550200; PA: EDB-97:142339; SN: 97001865621
DOE Contract Number:  
FG03-92ER20069
Resource Type:
Patent
Resource Relation:
Other Information: PBD: 23 Sep 1997
Country of Publication:
United States
Language:
English
Subject:
55 BIOLOGY AND MEDICINE, BASIC STUDIES; CELLULOSE; PROTEINS; BIOCHEMICAL REACTION KINETICS; DNA-CLONING; CHITIN; RECOMBINANT DNA

Citation Formats

Shoseyov, O., Shpiegl, I., Goldstein, M.A., and Doi, R.H. Methods of use of cellulose binding domain proteins. United States: N. p., 1997. Web.
Shoseyov, O., Shpiegl, I., Goldstein, M.A., & Doi, R.H. Methods of use of cellulose binding domain proteins. United States.
Shoseyov, O., Shpiegl, I., Goldstein, M.A., and Doi, R.H. Tue . "Methods of use of cellulose binding domain proteins". United States.
@article{osti_541745,
title = {Methods of use of cellulose binding domain proteins},
author = {Shoseyov, O. and Shpiegl, I. and Goldstein, M.A. and Doi, R.H.},
abstractNote = {A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques. 16 figs.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1997},
month = {9}
}